Pfizer : PFE

All Pfizer Articles

1489 Articles

Trey Thoelcke | May 25, 2016 at 6:10 AM EDT

The 5 Most Shorted NYSE Stocks: Short Sellers Pick a New Favorite

However, one medical supply company stood out, as short sellers piled on Baxter International in the first two weeks of…

Chris Lange | May 19, 2016 at 10:20 AM EDT

8 Stocks on the Move After ASCO Cancer Abstracts

ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or…

Paul Ausick | May 16, 2016 at 7:50 AM EDT

Pfizer Pays $5.2 Billion for Anacor

Pfizer has announced that it has reached a definitive agreement to acquire Anacor Pharmaceuticals in a deal valued at more…

Chris Lange | May 12, 2016 at 7:40 AM EDT

ASCO Could Make or Break These 7 Cancer Drug Trials

The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society…

Chris Lange | May 11, 2016 at 8:45 AM EDT

Major Pharma Short Interest Continues to Recede

The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical…

Trey Thoelcke | May 11, 2016 at 6:20 AM EDT

The 5 Most Shorted NYSE Stocks: Short Sellers Still in Retreat

As the markets reached all-time highs last month, the short sellers were in retreat, judging by the moves in the…

Jon C. Ogg | May 10, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com,…

Lee Jackson | May 9, 2016 at 10:05 AM EDT

4 Top Blue Chip Dividend Stocks to Buy and Hold Forever

These stocks should do well for years regardless of who the next president is. They all have incredible franchises, long…

Paul Ausick | May 7, 2016 at 12:30 PM EDT

Analysts Adjust Predictions on Medivation Buyout Price

One time when missing earnings estimates doesn't matter much is when there is bidding war for the company. That's the…

Trey Thoelcke | May 5, 2016 at 7:35 AM EDT

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an…

Paul Ausick | May 3, 2016 at 4:01 PM EDT

The 5 Dow Stocks That Defied the Selling Tuesday

May 3, 2016: Markets opened lower Tuesday following some overnight weakness in overseas markets resulting from weak data on trade…

Paul Ausick | May 3, 2016 at 7:25 AM EDT

Pfizer Boosts Guidance With Help From Hospira, Weaker Dollar

Pfizer reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.

Chris Lange | May 2, 2016 at 12:15 PM EDT

What to Expect From Pfizer Earnings

Pfizer is scheduled to report its first-quarter financial results before the markets open on Tuesday.

Chris Lange | May 1, 2016 at 9:15 AM EDT

Top 6 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and some of the other major companies reporting…

Chris Lange | Apr 27, 2016 at 9:15 AM EDT

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

1 … 49 50 51 52 53 … 100

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted NYSE Stocks: Short Sellers Pick a New Favorite

8 Stocks on the Move After ASCO Cancer Abstracts

Pfizer Pays $5.2 Billion for Anacor

ASCO Could Make or Break These 7 Cancer Drug Trials

Major Pharma Short Interest Continues to Recede

The 5 Most Shorted NYSE Stocks: Short Sellers Still in Retreat

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

4 Top Blue Chip Dividend Stocks to Buy and Hold Forever

Analysts Adjust Predictions on Medivation Buyout Price

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

The 5 Dow Stocks That Defied the Selling Tuesday

Pfizer Boosts Guidance With Help From Hospira, Weaker Dollar

What to Expect From Pfizer Earnings

Top 6 Earnings for the Week Ahead

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted NYSE Stocks: Short Sellers Pick a New Favorite

8 Stocks on the Move After ASCO Cancer Abstracts

Pfizer Pays $5.2 Billion for Anacor

ASCO Could Make or Break These 7 Cancer Drug Trials

Major Pharma Short Interest Continues to Recede

The 5 Most Shorted NYSE Stocks: Short Sellers Still in Retreat

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

4 Top Blue Chip Dividend Stocks to Buy and Hold Forever

Analysts Adjust Predictions on Medivation Buyout Price

3 Big Pharma Stocks With Credible Threats to Their Blockbusters

The 5 Dow Stocks That Defied the Selling Tuesday

Pfizer Boosts Guidance With Help From Hospira, Weaker Dollar

What to Expect From Pfizer Earnings

Top 6 Earnings for the Week Ahead

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

Is XRP About to Bounce? XRP FUD Just Hit the Same Low That Sparked a 50% Rally

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

Featured Reads

Retired and Considering Remarrying? Five Questions That Determine Whether You Should

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?